BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31404507)

  • 1. Association Between Self-Reported Hypertension and Antihypertensive Medication Use and Cardiovascular Disease-Related Events and Expenditures Among Patients Diagnosed With Hypertension.
    Baker-Goering MM; Howard DH; Will JC; Beeler Asay GR; Roy K
    Public Health Rep; 2019; 134(5):493-501. PubMed ID: 31404507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Antihypertensive Medication Adherence With Healthcare Use and Medicaid Expenditures for Acute Cardiovascular Events.
    Yang Z; Howard DH; Will J; Loustalot F; Ritchey M; Roy K
    Med Care; 2016 May; 54(5):504-11. PubMed ID: 27078823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
    Balu S
    Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Cost-Related Medication Nonadherence and Hypertension Management Among US Adults.
    Fang J; Chang T; Wang G; Loustalot F
    Am J Hypertens; 2020 Sep; 33(9):879-886. PubMed ID: 32369108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
    Hwang AY; Dave CV; Smith SM
    Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009.
    Davis-Ajami ML; Wu J; Fink JC
    Value Health; 2014; 17(1):51-61. PubMed ID: 24438717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental expenditure of treating hypertension in the United States.
    Balu S; Thomas J
    Am J Hypertens; 2006 Aug; 19(8):810-6; discussion 817. PubMed ID: 16876679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO).
    Krousel-Wood M; Holt E; Joyce C; Ruiz R; Dornelles A; Webber LS; Morisky DE; Frohlich ED; Re RN; He J; Whelton PK; Muntner P
    J Hypertens; 2015 Feb; 33(2):412-20. PubMed ID: 25304468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.
    Shin S; Song H; Oh SK; Choi KE; Kim H; Jang S
    Hypertens Res; 2013 Nov; 36(11):1000-5. PubMed ID: 23966057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and Costs Associated With Suboptimal Physical Activity Among US Women With Cardiovascular Disease.
    Okunrintemi V; Benson EA; Tibuakuu M; Zhao D; Ogunmoroti O; Valero-Elizondo J; Gulati M; Nasir K; Michos ED
    JAMA Netw Open; 2019 Apr; 2(4):e191977. PubMed ID: 30977851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension.
    Sheppard JP; Stevens S; Stevens R; Martin U; Mant J; Hobbs FDR; McManus RJ
    JAMA Intern Med; 2018 Dec; 178(12):1626-1634. PubMed ID: 30383082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.
    Ritchey M; Tsipas S; Loustalot F; Wozniak G
    PLoS One; 2016; 11(7):e0159366. PubMed ID: 27428008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-associated expenditures for medication among US adults.
    Wang G; Yan L; Ayala C; George MG; Fang J
    Am J Hypertens; 2013 Nov; 26(11):1295-302. PubMed ID: 23727748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial.
    Carling CL; Kristoffersen DT; Oxman AD; Flottorp S; Fretheim A; Schünemann HJ; Akl EA; Herrin J; MacKenzie TD; Montori VM
    PLoS One; 2010 Mar; 5(3):e9469. PubMed ID: 20209127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.